Search research articles
Contact Us
Filters
Showing results (61-70 of 153) with videos related to
Page
of 16
Sort By:
Bone Marrow Transplantation
|
December 1, 1993
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities
L Sutton, M Kuentz, C Cordonnier, et al.
Histopathology
|
July 1, 1994
bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma
D Schlaifer, P Brousset, M Attal, et al.
Annales De Radiologie
|
January 1, 1991
[Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases]
J Assoun, C Poey, M Attal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial
M Attal, D Schlaifer, H Rubie, et al.
Leukemia & Lymphoma
|
January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALL
E Racadot, C Sebban, C Boucheix, et al.
Bone Marrow Transplantation
|
January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)
D Blaise, D Guyotat, J Reiffers, et al.
European Journal of Immunology
|
April 1, 1993
Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy
J P Gaillard, R Bataille, H Brailly, et al.
Blood
|
August 15, 1995
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group
M Attal, D Blaise, G Marit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia
C Sebban, E Lepage, J P Vernant, et al.
Blood
|
September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation
D Blaise, D Olive, A M Stoppa, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 153) with videos related to
Sort By:
Page
of 16
Bone Marrow Transplantation
|
December 1, 1993
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities
L Sutton, M Kuentz, C Cordonnier, et al.
Histopathology
|
July 1, 1994
bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma
D Schlaifer, P Brousset, M Attal, et al.
Annales De Radiologie
|
January 1, 1991
[Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases]
J Assoun, C Poey, M Attal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial
M Attal, D Schlaifer, H Rubie, et al.
Leukemia & Lymphoma
|
January 1, 1994
Autologous BMT for post-remission therapy in adult ALL: an immunological approach. For The French Group of Therapy of Adult ALL
E Racadot, C Sebban, C Boucheix, et al.
Bone Marrow Transplantation
|
January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)
D Blaise, D Guyotat, J Reiffers, et al.
European Journal of Immunology
|
April 1, 1993
Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy
J P Gaillard, R Bataille, H Brailly, et al.
Blood
|
August 15, 1995
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group
M Attal, D Blaise, G Marit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia
C Sebban, E Lepage, J P Vernant, et al.
Blood
|
September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation
D Blaise, D Olive, A M Stoppa, et al.
Page
of 16